5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Super-resolution non-linear multimodal imaging platform for studying spatially correlated metabolic reactions
    Meeting Abstract

    Jang, H.; Li, Z.; Li, Y.; Bagheri, P.; Ackerstaff, E.; Koutcher, J. A.; Shi, L.
    Biophysical Journal (2023)

    Fulltext@MSK | Save
  • Cancer associated macrophage-like cells are prognostic for highly aggressive prostate cancer in both the non-metastatic and metastatic settings
    Journal Article

    Gironda, D. J.; Bergan, R. C.; Alpaugh, R. K.; Danila, D. C.; Chuang, T. L.; Hurtado, B. Y.; Ho, T.; Adams, D. L.
    Cancers (2023)

    Fulltext@MSK | Save
  • Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CT
    Journal Article

    McLaughlin, L. A.; Yildirim, O.; Rosenblum, M. K.; Imber, B. S.; Haseltine, J. M.; Zelefsky, M. J.; Schöder, H.; Morris, M. J.; Rafelson, W. M.; Krebs, S.; more...
    Journal of Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Experience with the US health care system for Black and White patients with advanced prostate cancer
    Journal Article

    Rencsok, E. M.; Stopsack, K. H.; Slopen, N.; Odedina, F. T.; Ragin, C.; Nowak, J.; McSwain, L.; Manarite, J.; Heath, E.; George, D. J.; more...
    Cancer (2023)

    Fulltext@MSK | Save
  • Combining next-generation hormonal therapy with PARP inhibition in metastatic castration-resistant prostate cancer
    Editorial

    Abida, W.; Attard, G.
    Lancet (2023)

    Fulltext@MSK | Save
  • Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): A multicentre, randomised, open-label, phase 3 trial
    Journal Article

    Pal, S. K.; Albiges, L.; Tomczak, P.; Suárez, C.; Voss, M. H.; de Velasco, G.; Chahoud, J.; Mochalova, A.; Procopio, G.; Mahammedi, H.; more...
    Lancet (2023)

    Fulltext@MSK | Save
  • Prognostic factors for survival in patients undergoing surveillance after cytoreductive nephrectomy
    Journal Article

    Reese, S. W.; Khaleel, S.; Silagy, A.; Xie, A.; Eismann, L.; Vazquez-Rivera, K.; Oparanozie, A.; Patil, S.; Coleman, J.; Motzer, R.; more...
    Journal of Urology (2023)

    Fulltext@MSK | Save
  • Reply by authors
    Correspondence

    Reese, S. W.; Khaleel, S.; Silagy, A.; Xie, A.; Eismann, L.; Vazquez-Rivera, K.; Oparanozie, A.; Patil, S.; Coleman, J.; Motzer, R.; more...
    Journal of Urology (2023)

    Fulltext@MSK | Save
  • Health-related quality of life in GALAHAD: A multicenter, open-label, phase 2 study of niraparib for patients with metastatic castration-resistant prostate cancer and DNA-repair gene defects
    Journal Article

    Smith, M. R.; Sandhu, S.; George, D. J.; Chi, K. N.; Saad, F.; Thiery-Vuillemin, A.; Stàhl, O.; Olmos, D.; Danila, D. C.; Gafanov, R.; more...
    Journal of Managed Care & Specialty Pharmacy (2023)

    Fulltext@MSK | Save
  • Safety and activity of immune checkpoint inhibitors in people living with HIV and cancer: A real-world report from the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium
    Journal Article

    El Zarif, T.; Nassar, A. H.; Adib, E.; Fitzgerald, B. G.; Huang, J.; Mouhieddine, T. H.; Rubinstein, P. G.; Nonato, T.; McKay, R. R.; Li, M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save